Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
LLY | Eli Lilly and Company | 67.5 | ¤673,574 | US |
NOVO.B.DK | Novo Nordisk A/S Class B | 71.1 | ¤251,481 | DK |
MRK | Merck & Co., Inc. | 62.3 | ¤218,231 | US |
ISRG | Intuitive Surgical, Inc. | 63.7 | ¤170,692 | US |
AMGN | Amgen Inc. | 61.9 | ¤158,128 | US |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
SRPT | Sarepta Therapeutics, Inc. | 50.3 | ¤1,976 | US |
LNTH | Lantheus Holdings Inc | 71.5 | ¤3,958 | US |
SFZN.CH | Siegfried Holding AG | 52.7 | ¤4,674 | CH |
326030.KR | SK Biopharmaceuticals Co., Ltd. | 79.3 | ¤5,572 | KR |
HLUN.B.DK | H. Lundbeck A/S Class B | 69.2 | ¤6,151 | DK |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
NOVO.B.DK | Novo Nordisk A/S Class B | 71.1 | 36 | DK |
BIIB | Biogen Inc. | 59.8 | 30 | US |
AMGN | Amgen Inc. | 61.9 | 29 | US |
ISRG | Intuitive Surgical, Inc. | 63.7 | 25 | US |
REGN | Regeneron Pharmaceuticals, Inc. | 62.9 | 23 | US |
RMD | ResMed Inc. | 73.0 | 23 | US |
EW | Edwards Lifesciences Corporation | 42.7 | 22 | US |
LLY | Eli Lilly and Company | 67.5 | 21 | US |
4507.JP | Shionogi & Co., Ltd. | 66.4 | 20 | JP |
4519.JP | Chugai Pharmaceutical Co., Ltd. | 62.4 | 19 | JP |
Average Market Cap | ¤54,051 |
Median Market Cap | ¤15,026 |
Avg. 3 Mo. Dollar Vol. | ¤321,708,086 |
Avg. 3 Mo. Trading Vol. | 3,564,102 |
Last Rebalance Date | 03/24/2025 |
Companies Replaced | 16 |
Biggest Industry Increase | Pharmaceuticals: Major |
Biggest Industry Decrease | Medical Specialties |
Trailing P/E Ratio (12 Mo.) | 24.0 |
Forward P/E Ratio (12 Mo.) | 19.0 |
Price/Book Ratio | 4.9 |
Avg. Revenue Chg. - 3 Yr | 39.1% |
Avg. Op. Income Chg. - 3 Yr. | 53.6% |
Avg. EPS Growth - 3 Yr. | 16.0% |
Avg. EPS Growth - 1 Yr. | 11.5% |
Avg. Operating Margin | 23.8% |
Avg. LT Debt to Total Capital | 34.2% |
Avg. Return on Equity | 19.2% |
Dividend Yield | 0% |
Developed Markets (ex-Australia) Health Care Index | 62.33 |
United States Of America | 68.0% |
Japan | 12.0% |
Denmark | 8.0% |
Korea, Republic Of | 4.0% |
Sweden | 2.0% |
Finland | 2.0% |
Ireland | 2.0% |
Switzerland | 2.0% |